Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-06-05-Speech-4-216"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20080605.30.4-216"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
". −
The Commission proposes to exclude pet animals from the scope of Council Directive 96/22/EC which would enable their treatment with substances having a thyrostatic action and with beta-agonists.
This important measure is intended to reduce the suffering of pet animals and will allow the use, for example, of substances having a thyrostatic action for the treatment of hyperthyroidism in these animals.
However, the most recent developments in scientific assessment tell us that using these substances is economically unattractive in animal production for human consumption or can be replaced with alternative substances.
It is therefore proposed to prohibit entirely the use of oestradiol 17 ß and its esters in animal production for human consumption, putting an end to the various derogations that still exist today. I would point out that these hormones, when used to promote growth, can be carcinogenic to human beings and that the existing derogations can finally be ended as these hormones can be replaced with alternative substances without any problems.
These changes will ensure a high level of protection for consumers of meat and animal derivatives while at the same time allowing the treatment and reduction of suffering of pet animals."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples